PTGX - Company ID 0001377121
As of 2026-09-07, Protagonist Therapeutics, Inc (PTGX) has a market capitalization of $9.37 B, making it the #1002 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-09-07 | $9.37 B |
| 2026-09-06 | $9.37 B |
| 2026-09-05 | $9.37 B |
| 2026-09-04 | $9.37 B |
| 2026-09-03 | $9.57 B |
| 2026-09-02 | $9.39 B |
| 2026-09-01 | $9.42 B |
| 2026-08-31 | $9.43 B |
| 2026-08-30 | $9.28 B |
| 2026-08-29 | $9.28 B |
| 2026-08-28 | $9.22 B |
| 2026-08-27 | $9.61 B |
As of 2026-09-07, Protagonist Therapeutics, Inc (PTGX) has a market capitalization of $9.37 B, making it the #1002 most valuable US-listed company.
Protagonist Therapeutics, Inc is the #1002 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-08-26 | $9.74 B |
| 2026-08-25 | $9.78 B |
| 2026-08-24 | $9.95 B |
| 2026-08-23 | $9.92 B |
| 2026-08-22 | $9.92 B |
| 2026-08-21 | $9.92 B |
| 2026-08-20 | $9.69 B |
| 2026-08-19 | $9.96 B |
| 2026-08-18 | $10.17 B |
| 2026-08-17 | $10.20 B |
| 2026-08-16 | $9.97 B |
| 2026-08-15 | $9.97 B |
| 2026-08-14 | $9.95 B |
| 2026-08-13 | $9.74 B |
| 2026-08-12 | $9.78 B |
| 2026-08-11 | $9.54 B |
| 2026-08-10 | $9.56 B |
| 2026-08-09 | $9.38 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.